Therapy said superior to a basal/bolus insulin regimen at lowering HbA1c with less hypoglycemia and weight gain.

GLP-1 receptor agonists vs DPP-4 inhibitors: In head-to-head trials of dipeptidyl peptidase 4 (DPP-4) inhibitors vs glucagon-like peptide 1 (GLP-1) receptor agonists, GLP-1 receptor agonists showed more favorable outcomes in all of the following areas except which one of the following? A. Greater glycemic control B. Greater tolerability C. Greater weight loss D. Greater improvement in beta-cell function E. Greater reduction in postprandial triglycerides Follow the link to see if you got it right!

When was the last time you rode a bike? a) Days b) Weeks c) Months d) Years e) Decades ago f) Never! Follow the link to see how you compare to your colleagues!

Last week, I was listening to our good friend Joe Graedon from the People’s Pharmacy on my local NPR station. He had a researcher on who was talking about the different kinds of fat and what they do to your body. One of the things she pounded on was the …

Woman, 63 years of age, history of ovarian cancer, prediabetes, hyperlipidemia, has been trying to lose weight for years but was unable to do so. She is very family-, friend-, colleague-oriented. Every holiday she thought she had to make or bring and eat whatever special holiday food was associated with the holiday. She couldn’t let anyone down by not bringing, or by not eating what other people brought. We met weekly for the past three years. Every week there was some excuse about how or why she “cheated” or if there was a week she didn’t think she “cheated,” then she was afraid she would.

In this Exclusive Interview transcript, Dr. Richard Bergenstal discusses the first approval of a hybrid closed-loop system and the future of diabetes treatment, including a possible cure for type 1 diabetes.

In this Exclusive Interview, Dr. Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed about the technology in the artificial pancreas, the new Abbott Libre CGMS, and the possible diabetes cure.

In this week's Homerun Slides, talking to patients about SGLT-2 as a treatment option.

The glucose transport effector system, GLUT4 vesicle translocation and trafficking: Glucose transport proteins are the key functional units of the glucose transport effector system. Multiple glucose transporter genes have been identified that encode a family of homologous proteins exhibiting different functional properties and marked differences in tissue-specific expression.

In 2006, I had the distinction of doing more education programs for the DIN network than anyone else in the program. Our publisher, Steve Freed, was also part of the more that 400 educators that delivered 1-hour programs to thousands of patients. This was a real change from the all-day …